MKI67 and neoplasm: In addition, the proportion of Ki67-positive cells in the FOLFIRINOX MN group (9.0 ± 2.4%) was significantly less than that in the other three groups, suggesting the decreased proliferation ability of tumor cells (Figure 6(b) and Figure S5).